RxDoctor Payments Data

Ronald Roth

Cardiovascular Disease · Parowan, UTNPI 1497795389

Payments from drug & device makers

$2,346in general payments, 2019–2025

Across 136 payments — averaging $17.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$433
  • Johnson & Johnson$290
  • Sanofi-aventis U.S. LLC$255
  • Novartis$243
  • Boehringer Ingelheim$199
  • Pfizer$151
  • plus $775 from 14 others

What the payments were for

  • Food & beverage$2,32099%
  • Education$251%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,346 in reported general payments places this provider in the 50th percentile of 131 cardiovascular disease providers in Utah.

See all cardiovascular disease providers in Utah

Other cardiovascular disease in Parowan

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →